Louks Ronald Allen 4
4 · NantHealth, Inc. · Filed Sep 9, 2021
Insider Transaction Report
Form 4
Louks Ronald Allen
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-09-08$0.55/sh+4,700$2,585→ 230,557 total - Sale
Common Stock
2021-09-08$2.25/sh−4,700$10,583→ 225,857 total - Exercise/Conversion
Stock Option (right to buy)
2021-09-07−16,613→ 531,882 totalExercise: $0.55Exp: 2029-08-12→ Common Stock (16,613 underlying) - Sale
Common Stock
2021-09-07$2.30/sh−16,613$38,148→ 225,857 total - Exercise/Conversion
Common Stock
2021-09-03$0.55/sh+1,505$828→ 227,362 total - Sale
Common Stock
2021-09-03$2.34/sh−1,505$3,515→ 225,857 total - Exercise/Conversion
Common Stock
2021-09-07$0.55/sh+16,613$9,139→ 242,470 total - Exercise/Conversion
Stock Option (right to buy)
2021-09-03−1,505→ 548,495 totalExercise: $0.55Exp: 2029-08-12→ Common Stock (1,505 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-09-08−4,700→ 527,182 totalExercise: $0.55Exp: 2029-08-12→ Common Stock (4,700 underlying)
Footnotes (4)
- [F1]Represents the weighted average share price of an aggregate total of 1,505 shares sold in the price range of $2.31 to $2.38 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 16,613 shares sold in the price range of $2.25 to $2.32 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 4,700 shares sold in the price range of $2.25 to $2.26 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Subject to the reporting person continuing as a service provider, the shares subject to the option shall vest as follows, fifty percent (50%) of the shares subject to the option shall vest on the one (1) year anniversary from the date of grant, and twenty-five percent (25%) of the remaining shares subject to the option shall vest annually thereafter, so that the option is fully vested on the three (3) year anniversary date.